Filing Details

Accession Number:
0001127602-14-000151
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-02 15:15:25
Reporting Period:
2013-12-31
Filing Date:
2014-01-02
Accepted Time:
2014-01-02 15:15:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
912183 Cubist Pharmaceuticals Inc CBST Pharmaceutical Preparations (2834) 223192085
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379970 C Steven Gilman 65 Hayden Avenue
Lexington MA 02421
Evp & Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-12-27 192 $0.00 22,859 No 5 G Direct
Common Stock Acquisiton 2013-12-27 192 $0.00 23,051 No 5 G Direct
Common Stock Acquisiton 2013-12-30 190 $0.00 23,241 No 5 G Direct
Common Stock Acquisiton 2013-12-31 188 $0.00 23,429 No 5 G Direct
Common Stock Acquisiton 2013-12-31 111 $42.59 23,540 No 4 J Direct
Common Stock Acquisiton 2014-01-02 25,000 $18.69 48,540 No 4 M Direct
Common Stock Disposition 2014-01-02 24,490 $67.80 24,050 No 4 S Direct
Common Stock Disposition 2014-01-02 510 $68.65 23,540 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Direct
No 5 G Direct
No 5 G Direct
No 4 J Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2014-01-02 25,000 $0.00 25,000 $18.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-06-14 2018-03-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,633 Indirect 401(k) Plan
Footnotes
  1. Shares purchased pursuant to employee stock purchase plan.
  2. Sold pursuant to a 10(b)5-1 Plan
  3. This transaction was executed in multiple trades at prices ranging from $67.3400 to $68.2700. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $68.4100 to $68.6500. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  5. Option vests 6.25% quarterly over a four-year period.